Inhibition of SHP2 in Basal-Like and Triple-Negative Breast Cells Induces Basal-To-Luminal Transition, Hormone Dependency, and Sensitivity to Anti-Hormone Treatment

BMC Cancer - United Kingdom
doi 10.1186/s12885-015-1131-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2013English

Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?

Journal of Oncology
Oncology
2020English

SHP2 Acts Both Upstream and Downstream of Multiple Receptor Tyrosine Kinases to Promote Basal-Like and Triple-Negative Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2016English

Are Triple Negative Tumours and Basal-Like Breast Cancer Synonymous?

Breast Cancer Research
Cancer ResearchOncology
2007English

Triple-Negative (Basal-Like) Breast Cancer: A New Entity

Breast Cancer Research
Cancer ResearchOncology
2007English

miRNA-135b Contributes to Triple Negative Breast Cancer Molecular Heterogeneity: Different Expression Profile in Basal-Like Versus Non-Basal-Like Phenotypes

International Journal of Medical Sciences
Medicine
2018English

Triple-Negative Breast Cancer: Clinicopathological Characteristics and Relationship With Basal-Like Breast Cancer

Modern Pathology
Forensic MedicinePathology
2009English

Basal Markers and Prognosis in Luminal Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2017English

Parathyroid Hormone–like Hormone Induces Epithelial-To-Mesenchymal Transition of Intestinal Epithelial Cells by Activating the Transcription Factor Runx2

American Journal of Pathology
Forensic MedicinePathology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy